Document is current
Any future updates will be listed below
-
Authors
Fan, Jieqing
Liu, Danyang
Ming, Zhu
Yan, Chunyu
Dang, Huaixin
Pan, Yanfang
Wei, Xiong
Zhao, Zhengle
Wang, Wenzhi
Zhang, Shuai
Chen, Linlin
Cai, Shuo
Ke, Jiangbin
Luo, Yaru
Rao, Linjie
Chen, Jingjing
Chen, Zhenjie
Zhou, Junlin
Chen, Feixiang
Duan, Xiaodi
Ren, Boyue
Li, Tong-Ruei R.
Melvin, Lawrence
Yogaratnam, Jeysen
Mahajan, Vinit B.
Song, Hongmei
Lichenstein, Henri
Xu, Tian
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 18 August 2025
First Online: 9 September 2025
Competing interests
: Jieqing Fan, Danyang Liu, Zhu Ming, Chunyu Yan, Yanfang Pan, Huaixin Dang, Xiong Wei, Zhengle Zhao, Wenzhi Wang, Zhenjie Chen, Junlin Zhou, Shuai Zhang, Tong-Ruei R Li, Lawrence Melvin, Jeysen Yogaratnam, Henri Lichenstein, Tian Xu, and Cong Xu own stock in Drug Farm Inc., which funded this work and is the parent company of Shanghai Yao Yuan Biotechnology Ltd, Zhejiang Yao Yuan Biotechnology Ltd, and Drug Farm USA LLC. Vinit Mahajan is a consultant for Drug Farm. Danyang Liu, Cong Xu, Lawrence Melvin, Wei Xiong, Tongruei Raymond Li, Jieqing Fan, Yanfang Pan, Huaixin Dang, Henri Lichenstein and Tian Xu are inventors on two international patent applications filed by Shanghai Yao Yuan Biotechnology Ltd. (PCT/CN2021/119801, filed on September 23 2021, and #19/036,564, filed on January 24, 2025), which are based on the work described in the article. The remaining authors declare no competing interests.
